Numbers

The Numbers

Daqo trades at $19.14 per ADR with a $1.30B market cap and $1.94B in cash, no debt, and a parent-attributable book value of $65.43 per share. The market is pricing the polysilicon producer below its share of net cash because two consecutive years of negative gross margins have created real doubt about whether the next cycle ever arrives. The single number that will rerate or derate this stock is the polysilicon spot price — every line on every chart below maps to that one variable with brutal precision.

Snapshot

Health & Durability Scorecard

The asset-quality picture is dominated by one fact: zero debt, current ratio above 5x, and inventory and receivables both well below their 2022 boom highs. The earnings-quality picture is the opposite — operating income has been negative for eight consecutive quarters and the latest quarter (Q1 2026) saw revenue collapse to $26.7M as the company throttled production into the trough.

The mix is unusual: a balance sheet that would qualify as investment-grade if it carried debt, paired with an income statement that reads like a distressed manufacturer. Liquidity buys time; what it cannot buy is a polysilicon price recovery.

Revenue & Earnings Power

Daqo's eight-year income statement is a clean cycle: a cost-curve-driven base business through 2019, a once-in-a-decade margin spike from 2020 through 2022 as polysilicon spot prices ran from $10/kg to over $35/kg, then a violent reversion as Chinese capacity additions overwhelmed end-demand. Revenue peaked at $4.6B in 2022 and has fallen 86% in three years. Operating income swung from a $3.0B profit to a $0.56B loss over the same window.

The margin chart is the cleanest expression of the polysilicon cycle: from a 33% gross margin baseline, the spot-price spike pushed gross margins above 73% — a number that should never have anchored expectations but did. Today's negative gross margin means the cash cost of polysilicon production exceeds the realized selling price; this is the textbook bottom-of-cycle signature for a commodity producer.

Quarterly Trajectory — The Trough Deepens

Q3 and Q4 of 2025 looked like a stabilization — revenue rebuilding to $220M+, op losses narrowing to $20M, EBITDA briefly positive. Q1 2026 erased that progress: revenue collapsed 88% sequentially to $26.7M as Daqo participated in the industry-wide self-discipline regime designed to clear inventory. The op loss widened back to $151M. Whether this is a coordinated supply cut that pulls forward a price recovery, or a disorderly collapse, will determine whether 2026 looks like 2020 or 2012.

Cash Generation — Are the Earnings Real?

Earnings quality during the up-cycle was excellent: trailing five-year CFO/NI averaged 1.7x as Daqo collected on inflated polysilicon prices faster than it accrued the income. The downside has been ugly but not abusive — even with FY24 operating losses of $564M, operating cash drain was $435M, and FY25 CFO turned slightly positive on working-capital release. The depreciation tail from the $5B capex binge of 2021-2023 ($210-240M annually) now flows through the income statement long after the cash has left.

Capex compounded the cycle: $1.2B spent at the absolute peak in 2022, $1.1B in 2023, then a reluctant pullback to $173M in 2025. The pre-2024 capex built a 305,000-MT capacity base that today runs at a fraction of nameplate.

Capital Allocation

Daqo deployed the cash windfall responsibly: $615M of buybacks across FY22-FY24, no dividend, no acquisitions, full debt extinguishment by 2021. Buybacks went silent in FY25 as cash flow turned, which is the right discipline. The SBC bill spiked to $307M in 2022 — that is 6.7% of revenue and a real cost shareholders bore alongside the buyback — but normalized back to $56M in 2025 as the equity price collapsed and earn-outs deflated.

Balance Sheet — The Cash Buffer

The crossover happened twice: late 2022 and again in early 2026. Cash on the balance sheet now exceeds the entire equity market cap by $647M. The footnote that matters: roughly 25% of consolidated cash sits at Xinjiang Daqo (the separately listed Shanghai-traded subsidiary) and is not directly distributable to ADR holders. On a parent-attributable basis the cash claim is roughly $21 per ADR — still above today's $19.14 price, but with a much thinner margin of safety than the headline number suggests.

Valuation — Now vs Its Own History

P/B is the only valuation lens that survives an environment where earnings, EBITDA, and free cash flow are all negative. At 0.29x book value, DQ trades at the steepest discount in its public history. The eight-year average is roughly 1.4x — a polysilicon producer should normally trade at a discount to book given commodity risk, but this discount implies the market expects book value itself to deteriorate by 70% before stabilizing.

Stock Price — Cycle Memory

The 2021 intraday peak was $124. Today's $19.14 is an 85% drawdown from that peak and a 35% drawdown from year-end 2025. Polysilicon stocks are violent vehicles — owning one is implicitly a leveraged call on a single commodity price.

Peer Comparison

The peer set splits cleanly into three groups: First Solar is the only profitable scaled producer (and trades at 8x DQ's revenue multiple); Wacker Chemie is the German polysilicon comp running at modest profitability with positive net debt; and the Chinese module names (Canadian Solar, JinkoSolar) carry net debt loads ($6.3B and $15.6B respectively) that dwarf their market caps. Daqo is unique in the set as the only company combining net cash with deeply negative operating margins. That combination is what creates the deep P/B discount — investors are not asking "how cheap is the franchise" but "how fast does the cash burn?"

Per-Share Economics

Share count is stable. Diluted shares were 76.8M at the boom-time peak, fell to 67.4M after the 2023 buyback, and have not moved meaningfully since. There is no dilution overhang — the shareholder base today owns essentially the same fractional claim it owned at the start of 2024, with $615M of buybacks executed at an average price of roughly $40-50 (i.e. heavily underwater versus today's price).

Fair Value Scenarios

Anchoring on book value is the only honest valuation lens for a profitless commodity producer with a fortress balance sheet. The bear case ($13) assumes two more years of operating losses chew through 30% of book; the base case ($55) requires polysilicon to stabilize at cash-cost economics with the parent earning a normal-cycle 8-10% return on tangible capital; the bull case ($98) requires a genuine demand recovery combined with the sustained capacity discipline that is only just beginning to show in Q1 2026 production cuts. Consensus analyst target sits at $25.43 — between the bear and base cases, suggesting the Street is similarly anchoring on book-value erosion as the central scenario.

Bottom Line

The numbers confirm what the popular narrative says about Daqo's balance sheet — net cash above market cap, no debt, a current ratio above 5x — but they contradict the equally popular narrative that the cash buffer is a margin of safety. Two consecutive years of negative gross margins mean the cash is being actively consumed; without a polysilicon price recovery, the bear case becomes the base case within twelve months. The single observation that would most change the thesis is sequential gross margin direction in Q2 2026 — not the absolute level, but whether industry self-discipline narrows the loss faster than analysts expect, or whether the Q1 2026 revenue collapse to $26.7M is the start of a new leg lower.